Jan 17, 2023
New drug combination may effectively treat often fatal childhood brain tumor
Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...
Jan 12, 2023
New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...
Jan 6, 2023
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute...
Jul 19, 2022
Why Do Pediatric Drugs Take So Long to Develop?
When it comes to treatment for cancer, and many chronic conditions in children, it often takes much longer to get new drugs and therapies...
Jun 16, 2022
Bortezomib extends survival of children with newly diagnosed T-cell lymphoblastic lymphoma
The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell ...
Jan 19, 2022
FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...
Jul 2, 2021
FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma
New FDA approval means that pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lympoblastic lymphoma who are...
Mar 26, 2021
Pediatric cancers have unique genetic vulnerabilities
Most cancer drugs that target specific genetic mutations are designed for adult cancers rather than those in children, partly because ...
Mar 19, 2020
PD-1 Blocker Safe in Childhood Cancers. But Does It Work?
PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were...
Nov 5, 2019
Chemotherapy sometimes set the stage for drug-resistant leukemia at relapse
An international collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia...